Cancer Risk in Patients with Down Syndrome—A Retrospective Cohort Study from Germany
Cancers · 09.03.2024 · 16 (6) · 1103
DOI: 10.3390/cancers16061103 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancers, online erschienen am 09.03.2024. Verfasst von Sarah Krieg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inclusive Medicine, University Hospital Ostwestfalen-Lippe, Bielefeld University, 33617 Bielefeld, Germany. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Access Publication Fund of Bielefeld University, Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
Background
Individuals with Down syndrome are thought to have a unique tumor profile.
Methods
Using the IQVIA Disease Analyzer database, patients aged ≥18 years diagnosed with Down syndrome in German general practices between 2005 and 2021 were compared with patients without Down syndrome for cancer incidence, adjusting for age, sex, average annual visit frequency, and comorbidity. The 5-year cumulative incidence of cancer overall and specific cancers was analyzed using Kaplan–Meier curves and compared using the log-rank test. In addition, univariable Cox regression analysis was performed.
Results
A total of 2438 patients with Down syndrome and 12,190 patients without Down syndrome were included; 3.9% of patients without Down syndrome and 3.1% of patients with Down syndrome were diagnosed with cancer (p = 0.143). Regression analysis showed no significant association between Down syndrome and subsequent cancer in the total population (HR: 0.79; 95% CI: 0.57–1.09), in women (HR: 0.89; 95% CI: 0.56–1.37), or in men (HR: 0.69; 95% CI: 0.43–1.11). Analyses by cancer type and sex showed a strong but not significant negative association between Down syndrome and breast cancer in women (HR: 0.33; 95% CI: 0.12–0.93).
Conclusions
Our results could form the basis for future studies to clarify whether and to what extent an adapted screening program needs to be modified for individuals with Down syndrome due to the particular cancer distribution pattern.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Inclusive Medicine, University Hospital Ostwestfalen-Lippe, Bielefeld University, 33617 Bielefeld, Germany.
- Department of General and Visceral Surgery, Thoracic Surgery and Proctology, University Hospital Herford, Medical Campus OWL, Ruhr University Bochum, 32049 Herford, Germany.
- Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine University Duesseldorf, 40225 Duesseldorf, Germany.
- Epidemiology, IQVIA, 60549 Frankfurt, Germany.
ORCID-Profile: Sven H Loosen, Karel Kostev
Förderung
- Open Access Publication Fund of Bielefeld University
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Krieg, S., Krieg, A., Loosen, S. H., Roderburg, C., & Kostev, K. (2024). Cancer Risk in Patients with Down Syndrome—A Retrospective Cohort Study from Germany. Cancers, 16(6), 1103. https://doi.org/10.3390/cancers16061103
Vancouver
Krieg S, Krieg A, Loosen SH, Roderburg C, Kostev K. Cancer Risk in Patients with Down Syndrome—A Retrospective Cohort Study from Germany. Cancers. 2024;16(6):1103. doi:10.3390/cancers16061103
BibTeX
@article{Krieg2024,
author = {Krieg, Sarah and Krieg, Andreas and Loosen, Sven H and Roderburg, Christoph and Kostev, Karel},
title = {Cancer Risk in Patients with Down Syndrome—A Retrospective Cohort Study from Germany},
journal = {Cancers},
year = {2024},
volume = {16},
number = {6},
pages = {1103},
doi = {10.3390/cancers16061103}
}
EUVIMED